Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 94Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Atripla

02 3Sustiva

03 2Sustiva

04 1Truvada

PharmaCompass

01

Brand Name : Atripla

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Atripla

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 349

2019 Revenue in Millions : 600

Growth (%) : -42

blank

02

Brand Name : Atripla

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Atripla

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 145

2020 Revenue in Millions : 349

Growth (%) : -58

blank

03

Brand Name : Atripla

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Atripla

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 0

2021 Revenue in Millions : 145

Growth (%) : -100

blank

04

Brand Name : Sustiva

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Sustiva

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2014 Revenue in Millions : -10.50%

2013 Revenue in Millions :

Growth (%) :

blank

05

Brand Name : Sustiva

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Sustiva

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2015 Revenue in Millions : 1,444

2014 Revenue in Millions : 1,252

Growth (%) : -13%

blank

06

Brand Name : Atripla

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Atripla

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2015 Revenue in Millions : 3,470

2014 Revenue in Millions : 3,134

Growth (%) : -10%

blank

07

Brand Name : Sustiva

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Sustiva

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2017 Revenue in Millions : 729

2016 Revenue in Millions : 1,065

Growth (%) : -32

blank

08

Brand Name : Sustiva

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Sustiva

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2016 Revenue in Millions : 1,065

2015 Revenue in Millions : 1,252

Growth (%) : -15

blank

09

Brand Name : Sustiva

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Sustiva

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2018 Revenue in Millions : 283

2017 Revenue in Millions : 729

Growth (%) : -61%

blank

10

Brand Name : Atripla

Efavirenz

arrow
Antibody Engineering
Not Confirmed

Brand Name : Atripla

arrow
Antibody Engineering
Not Confirmed

Efavirenz

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2016 Revenue in Millions : 2,605

2015 Revenue in Millions : 3,134

Growth (%) : -17

blank